What initial labs are recommended for a 14-week pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Laboratory Tests for a 14-Week Pregnant Patient

At 14 weeks of pregnancy, the recommended initial laboratory tests include complete blood count, blood type and Rh status, serologic tests for syphilis, hepatitis B surface antigen, HIV screening, and aneuploidy screening. 1

Core Initial Laboratory Tests

Blood Tests

  • Complete blood count (CBC)
  • Blood type and Rh status determination
  • Antibody screen (indirect Coombs test)
  • Hepatitis B surface antigen
  • HIV screening
  • Syphilis serology
  • Rubella immunity status (if not previously documented)

Urine Tests

  • Urinalysis
  • Urine culture (to screen for asymptomatic bacteriuria)

Genetic Screening

  • Aneuploidy screening options:
    • Second trimester quadruple screening (15-20 weeks)
    • Cell-free DNA screening (can be performed anytime after 10 weeks)
    • Integrated screening (combining first and second trimester markers)

Additional Tests Based on Risk Factors

  • Hepatitis C antibody testing for women with risk factors (e.g., history of injection drug use) 2
  • Chlamydia and gonorrhea screening, especially for women under 25 or with risk factors
  • Thyroid-stimulating hormone (TSH) measurement when indicated 3
  • Hemoglobin electrophoresis for women at risk for hemoglobinopathies
  • Glucose challenge test for early gestational diabetes screening in high-risk women (standard screening occurs at 24-28 weeks)

Timing Considerations

  • The optimal time for neural tube defect screening is 16-18 weeks, but screening is acceptable between 15.0 and 20.9 weeks 3
  • Screening performance is significantly decreased in the 14th week of gestation for some tests 3
  • First trimester ultrasound with crown-rump length measurement is recommended for pregnancy dating, providing accuracy within ±7 days 1

Important Considerations

  • Gestational age should be expressed in completed weeks (e.g., 15 weeks and 5 days is 15 completed weeks) or decimal weeks (15.7 weeks) rather than rounded weeks 3
  • Ultrasound dating based on multiple measurements is accurate to within 10 days in the second trimester 1
  • For Rh-negative women, Rh immune globulin should be administered at 28 weeks gestation (1500 IU; 300 mcg) 1

Common Pitfalls to Avoid

  • Failing to screen for hepatitis B surface antigen, which is crucial for preventing perinatal transmission (97% screening compliance is achievable when incorporated into routine prenatal care) 4, 5
  • Delaying aneuploidy screening, as different options are available at different gestational ages
  • Using package insert (commercial) medians for test interpretation instead of laboratory-specific reference ranges 3
  • Forgetting to repeat antibody screening later in pregnancy for women with ongoing risk factors for infectious diseases 2

Remember that these laboratory tests form the foundation for appropriate prenatal care and help identify conditions that may affect maternal and fetal health throughout pregnancy.

References

Guideline

Pregnancy Care Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatitis C in pregnancy: screening, treatment, and management.

American journal of obstetrics and gynecology, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatitis B Surface Antigen Testing Among Pregnant Women, United States 2014.

The Pediatric infectious disease journal, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.